Ausgabe 6/2001
Inhalt (13 Artikel)
Open Access
Commentary
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
Philip L Hooper
Open Access
Review
Cytokines as new treatment targets in chronic heart failure
Jan Kristian Damås, Lars Gullestad, Pål Aukrust
Open Access
Research
How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)
Lutgarde Thijs, Jan A Staessen, Sonia Beleva, Willem H Birkenhäger, Christopher J Bulpitt, Hilde Celis, Astrid E Fletcher, Rumjana Kermova, Gastone Leonetti, Tovio Laks, Stefan Mantov, Choudomir Nachev, Cinzia Sarti, Jaakko Tuomilehto, Robert H Fagard
Open Access
Review
Therapeutic angiogenesis for cardiovascular disease
Yin-Shan Ng, Patricia A D'Amore
Open Access
Commentary
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight
Deepak L Bhatt, Eric J Topol
Open Access
Commentary
Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
Irene Gavras, Haralambos Gavras
Open Access
Review
Distal protection devices during percutaneous coronary and carotid interventions
Panayotis Fasseas, James L Orford, Ali E Denktas, Peter B Berger
Open Access
Commentary
Debate: Should statin be used in patients with heart failure?
Aldo Pietro Maggioni
Open Access
Editorial
A new era in hypertension research: discussing the findings of ALLHAT
Curt D Furberg
Open Access
Review
Biventricular pacing in heart failure: update on results from clinical trials
Guy Haywood